Irhythm Technologies Inc (IRTC) Stock Price, Quote & News

Company Profile

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG)...

Industry: Medical Devices

Sector: Healthcare

Phone: 415 632 5700

Website: www.irhythmtech.com

Address:

699 8th Street, Suite 600, San Francisco, United States

Iightning Nov. 26 at 1:59 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $185 Call | Enter: $8.81 Exit: $11.21 | Profit: 27.19% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 12:05 PM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $185 Call | Enter: $8.81 Exit: $11.21 | Profit: 27.19% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 1:01 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $185 Call | Enter: $8.81 Exit: $11.21 | Profit: 27.19% ROI | https://1ightning.com

0 · Reply

Maxwell_Osgood Nov. 23 at 12:47 AM

$IRTC yay!

0 · Reply

Iightning Nov. 21 at 10:18 PM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 1:32 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 10:56 PM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 7:15 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

BillionerOfKing Nov. 14 at 12:58 PM

$IRTC Current Stock Price: $168.52 Contracts to trade: $170 IRTC Nov 21 2025 Call Entry: $9.81 Exit: $12.99 ROI: 32% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

d_risk Oct. 31 at 8:03 AM

$IRTC - iRhythm Technologies Inc. Common Stock - 10Q - Updated Risk Factors iRhythm’s latest 10-Q risk factors spotlight heavy reliance on Zio Services, shifting Medicare and reimbursement risks, expanded regulatory and compliance scrutiny, new supply chain and AI integration challenges, detailed IP and international expansion threats, increased debt exposure, and the removal of ESG and cybersecurity risk details. #HealthcareTechnology #IntellectualProperty #SupplyChainRisk #RegulatoryCompliance #MedicareReimbursement 🟢 Added 🟠 Removed https://d-risk.ai/IRTC/10-Q/2025-10-30

0 · Reply

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 13, 2025, 5:00 PM EST - 17 days ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC

Nov 11, 2025, 8:05 AM EST - 19 days ago

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

Nov 5, 2025, 1:38 PM EST - 25 days ago

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

Nov 4, 2025, 4:30 PM EST - 26 days ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

Oct 31, 2025, 2:17 PM EDT - 4 weeks ago

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

Oct 30, 2025, 9:06 PM EDT - 4 weeks ago

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 4:05 PM EDT - 4 weeks ago

iRhythm Technologies Announces Third Quarter 2025 Financial Results

Oct 23, 2025, 5:00 PM EDT - 5 weeks ago

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 16, 2025, 4:30 PM EDT - 6 weeks ago

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

Sep 18, 2025, 1:30 PM EDT - 2 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

Sep 9, 2025, 5:01 PM EDT - 2 months ago

IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 29, 2025, 7:00 AM EDT - 3 months ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service

Aug 18, 2025, 12:53 PM EDT - 3 months ago

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies

Aug 18, 2025, 8:05 AM EDT - 3 months ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority

Aug 1, 2025, 11:49 AM EDT - 4 months ago

iRhythm (IRTC) Q2 Revenue Jumps 26%

Jul 31, 2025, 9:49 PM EDT - 4 months ago

iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 4 months ago

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Jul 25, 2025, 6:35 PM EDT - 4 months ago

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 17, 2025, 4:30 PM EDT - 4 months ago

iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025

Jul 11, 2025, 10:12 PM EDT - 5 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

Jul 7, 2025, 8:30 AM EDT - 5 months ago

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

Jun 23, 2025, 8:30 AM EDT - 5 months ago

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

Jun 17, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Jun 15, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 6 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 10, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Jun 8, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

Jun 5, 2025, 10:00 AM EDT - 6 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

May 2, 2025, 1:24 PM EDT - 7 months ago

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

May 1, 2025, 9:14 PM EDT - 7 months ago

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:10 PM EDT - 7 months ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

Apr 29, 2025, 6:05 PM EDT - 7 months ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 8:05 AM EDT - 7 months ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 17, 2025, 4:30 PM EDT - 8 months ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 16, 2025, 8:35 AM EDT - 8 months ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Mar 31, 2025, 8:05 AM EDT - 8 months ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Feb 21, 2025, 12:23 AM EST - 10 months ago

iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:05 PM EST - 10 months ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 14, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Feb 13, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out

Feb 12, 2025, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation

Feb 11, 2025, 10:00 AM EST - 10 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 6, 2025, 4:05 PM EST - 10 months ago

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Jan 14, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation

Jan 13, 2025, 8:30 AM EST - 11 months ago

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

Iightning Nov. 26 at 1:59 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $185 Call | Enter: $8.81 Exit: $11.21 | Profit: 27.19% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 12:05 PM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $185 Call | Enter: $8.81 Exit: $11.21 | Profit: 27.19% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 1:01 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $185 Call | Enter: $8.81 Exit: $11.21 | Profit: 27.19% ROI | https://1ightning.com

0 · Reply

Maxwell_Osgood Nov. 23 at 12:47 AM

$IRTC yay!

0 · Reply

Iightning Nov. 21 at 10:18 PM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 1:32 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 10:56 PM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 7:15 AM

1ightning® Options Trade Alert (Actionable) | Buy $IRTC Dec 19 $170 Call | Enter: $22.68 Exit: $39.72 | Profit: 75.16% ROI | https://1ightning.com

0 · Reply

BillionerOfKing Nov. 14 at 12:58 PM

0 · Reply

d_risk Oct. 31 at 8:03 AM

0 · Reply

theflynews Oct. 30 at 11:37 PM

Closing Bell Movers: Amazon soars to all-time highs on earnings - $IRTC - https://thefly.com/permalinks/entry.php/IRTCid4226288?1761867097C

0 · Reply

IsabellaDC Oct. 30 at 9:24 PM

Notable AH movers: $IRTC $RYAN $AMZN $ARDX $WDC and more..

0 · Reply

healthcareguru Oct. 30 at 8:59 PM

$IRTC short all day…this move is a joke. 😂👎 $IHI $IWM $XLV

0 · Reply

Doozio Oct. 30 at 8:38 PM

$IRTC gap n go FRYday after da Thursday 🐑 during 🐒🍌🧠⏰♾️

0 · Reply

RunnerSignals Oct. 20 at 7:30 PM

Analysts going bullish on $AAPL $IRTC $PEN $SONY $KEY today. https://stocksrunner.com/news/2025-10-20-stock-upgrades-today-where-analysts-see-real-money-being-made

0 · Reply

JarvisFlow Oct. 15 at 3:21 PM

Truist Securities has updated their rating for iRhythm Technologies ( $IRTC ) to Buy with a price target of 205.

0 · Reply

JarvisFlow Oct. 13 at 12:41 PM

BTIG has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Buy with a target price of 190 → 195.

0 · Reply

JarvisFlow Oct. 9 at 10:19 AM

Oppenheimer updates rating for iRhythm Technologies ( $IRTC ) to Outperform, target set at 145 → 105.

0 · Reply

JarvisFlow Oct. 7 at 5:43 PM

Citigroup has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to Buy with a target price of 183 → 205.

0 · Reply

JarvisFlow Oct. 7 at 5:38 PM

Evercore ISI Group has adjusted their stance on iRhythm Technologies ( $IRTC ), setting the rating to In-Line with a target price of 185 → 175.

0 · Reply

ChartChef Oct. 5 at 8:16 AM

$IRTC Healthcare technology innovation. Breaking to new highs. Institutional accumulation pattern evident. Momentum strong.

0 · Reply

V_nbt Sep. 25 at 2:19 PM

$IRTC somone pumps this all through the day and dumps in the very last hour !!!

0 · Reply

Market Cap	6.06B
Revenue (ttm)	591.84M
Net Income (ttm)	-113.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.14%
Debt to Equity Ratio	0.00

Volume	164,100
Avg Vol	439,880
Day's Range	N/A - N/A
Shares Out	32.22M
Stochastic %K	88%
Beta	1.13
Analysts	Strong Sell
Price Target	$218.57